Skip to main content
. 2016 Jul 29;95(30):e4160. doi: 10.1097/MD.0000000000004160

Figure 5.

Figure 5

Relationship between pre-APRI and recurrence-free survival of patients with small HCC after liver resection. Patients with a pre-APRI ≥1 were associated with a significant reduction in recurrence-free survival compared with patients with a pre-APRI <1 (log-rank test, P = 0.007). Pre-APRI = preoperative aspartate aminotransferase to platelet ratio index, HCC = hepatocellular carcinoma.